2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4353):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-78861
    Leflunomide impurity 7
    Leflunomide impurity 7 is an impurity of Leflunomide.
    Leflunomide impurity 7
  • HY-Y1675
    Rivastigmine impurity 12
    Rivastigmine impurity 12 (m-Methoxyacetophenone) is an impurity of Rivastigmine.
    Rivastigmine impurity 12
  • HY-128383
    1-Methylpyrrolidine
    		99.02%
    1-Methylpyrrolidine is a methylated pyrrolidine, and cation with thermal-origin negative nonlinear optical (self-defocusing) properties.
    1-Methylpyrrolidine
  • HY-101710
    Benzgalantamine
    		99.51%
    Benzgalantamine (GLN-1062) is a pro-agent of galantamine, used for the treatment for Alzheimer’s disease.
    Benzgalantamine
  • HY-137787
    Cyanosafracin B
    Cyanosafracin B is a starting material for synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650.
    Cyanosafracin B
  • HY-W034065
    3,5-Dihydroxyacetophenone
    		99.96%
    3,5-Dihydroxyacetophenone is a drug intermediate that can be used in the synthesis of the active stilbene dimer dehydro-δ-viniferin.
    3,5-Dihydroxyacetophenone
  • HY-N7503
    Psoralenoside
    		99.84%
    Psoralenoside is an orally active benzofuran glycoside. Psoralenoside is isolated from the fruits of Psoralea corylifolia. As a metabolite precursor, Psoralenoside undergoes deglycosylation by intestinal flora to form Psoralen (HY-N0053). Psoralenoside is applicable to research related to cancer and bacterial infections.
    Psoralenoside
  • HY-65254
    5-Amino-2-fluoropyridine
    		99.94%
    5-Amino-2-fluoropyridine is a fluorinated heterocyclic compound, which can be used for the synthesis of other active compounds.
    5-Amino-2-fluoropyridine
  • HY-E70137
    AMG 118 (Immobilized cephalosporin C acylase)
    AMG 118 Immobilized cephalosporin C acylase is an enzyme that catalyzes in immobilized form and is generally used in industrial catalytic production of the important pharmaceutical intermediate 7-aminocephalosporanic acid (7-ACA). It contains CPC acylase, a highly specialized beta-lactam acylase or peptidase that cleaves the amide bonds between beta-lactams.
    AMG 118 (Immobilized cephalosporin C acylase)
  • HY-40023
    (S)-1-Boc-3-hydroxypiperidine
    		98.94%
    (S)-1-Boc-3-hydroxypiperidine is a key precursor in the synthesis of the anticancer agent Ibrutinib (HY-10997).
    (S)-1-Boc-3-hydroxypiperidine
  • HY-32757
    5-Bromo-2-fluoro-3-methylpyridine
    5-Bromo-2-fluoro-3-methylpyridine (5-Bromo-2-fluoro-3-picoline) is a drug synthesis intermediate that can be used to synthesize an inhibitor of dihydroorotate dehydrogenase (DHODH).
    5-Bromo-2-fluoro-3-methylpyridine
  • HY-W004863
    4-Bromo-2-methylbenzoic acid
    		99.51%
    4-Bromo-2-methylbenzoic acid (4-Bromo-o-toluic acid) is an important compound that can be used in the synthesis of other active compounds.
    4-Bromo-2-methylbenzoic acid
  • HY-I0481
    8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
    		99.95%
    8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione is a drug intermediate for synthesis of various active compounds.
    8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
  • HY-78766
    3beta,6alpha,17beta-Trihydroxy-5alpha-androstane
    3beta,6alpha,17beta-Trihydroxy-5alpha-androstane is a drug intermediate for synthesis of various active compounds.
    3beta,6alpha,17beta-Trihydroxy-5alpha-androstane
  • HY-W107495
    3-Bromo-4-chloro-5-methoxybenzoic acid
    		99.05%
    3-Bromo-4-chloro-5-methoxybenzoic acid is a drug intermediate for synthesis of various active compounds.
    3-Bromo-4-chloro-5-methoxybenzoic acid
  • HY-W168956
    Acetazolamide impurity 2
    		98.80%
    Acetazolamide impurity 2 (NSC 231656) is an impurity of Acetazolamide.
    Acetazolamide impurity 2
  • HY-76996
    Tolterodine impurity 1
    Tolterodine impurity 1 is an impurity of Tolterodine (HY-A0024).
    Tolterodine impurity 1
  • HY-141479B
    Butyryl-Coenzyme A lithium hydrate
    Butyryl-Coenzyme A (Butyryl CoA) lithium hydrate is a short-chain acyl CoA that can synthesize Butyric acid (HY-B0350).
    Butyryl-Coenzyme A lithium hydrate
  • HY-W062336
    (3R,4R)-4-Fluoropyrrolidin-3-ol hydrochloride
    		98.0%
    (3R,4R)-4-Fluoropyrrolidin-3-ol hydrochloride is a drug intermediate for synthesis of various active compounds.
    (3R,4R)-4-Fluoropyrrolidin-3-ol hydrochloride
  • HY-W007584
    2,4-Dimethoxybenzyl alcohol
    		99.89%
    2,4-Dimethoxybenzyl alcohol, an aromatic alcohol, is a substrate of glucose-methanol-choline (GMC) oxidoreductase. GMC oxidoreductase displays the characteristics of an aryl-alcohol oxidase. 2,4-Dimethoxybenzyl alcohol can be used as a drug intermediate.
    2,4-Dimethoxybenzyl alcohol